AKT1 and melanoma: Indeed, the increased activation of insulin-like growth factor 1 receptor (IGF1R) by IGF1 can activate the RAF-MEK-ERK and/or PI3K-AKT pathways and may play a role in the development of melanoma resistance [34,43].